$SCNI News

Scinai Immunotherapeutics shares are trading higher after the company announced a $2.61 million private placement financing.

Scinai Immunotherapeutics shares are trading higher after the company announced a $2.61 million private placement financing.

Why Scinai Immunotherapeutics Stock Is Skyrocketing 90% Higher Today

Scinai Immunotherapeutics Enters Securities Purchase Agreement For Up To 5.21M ADS And Warrants Priced At $0.48 Per Unit

Scinai Immunotherapeutics Completes Strategic Corporate Reorganization Establishing CDMO Platform Alongside Streamlined R&D Organization

Scinai Immunotherapeutics shares are trading higher after the company reported a year-over-year increase in FY sales results.

Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration

Scinai Immunotherapeutics FY EPS $(3.56), Sales $1.311M Up From $658.000K YoY

Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026

Scinai Immunotherapeutics To Present Its Growing Pipeline Of Antibody-Based Therapeutics Targeting Autoimmune And Inflammatory Diseases At BIO-Europe Spring 2026

Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price

Scinai Immunotherapeutics Receives Non-Compliance Notification From Nasdaq

Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept

Scinai Executes Second Amendment To Binding Option Agreement For Acquisition Of PinCell And Submits Revised Application Under European FENG SMART Path Program

Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform

Scinai Expands Israel Innovation Authority Support For Robotic Aseptic Fill & Finish Platform

Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm

Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL

Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances

Scinai Awarded Israel Innovation Authority Grant to Expand Fill-and-Finish CDMO Capabilities